Abstract
Abstract Or116: Macrophage full-length TREM2 suppresses hepatic apolipoprotein C3 secretion and atherosclerosis in prediabetic hepatic steatosis
Arteriosclerosis, thrombosis, and vascular biology, Vol.46(Suppl_1)
05/2026
DOI: 10.1161/atvb.46.suppl_1.Or116
Abstract
Abstract only Prediabetes associates with hepatic steatosis, increased plasma triglyceride-rich lipoproteins (TRLs), and cardiovascular disease (CVD). Hepatic steatosis is linked to increased plasma levels of soluble TREM2 (sTREM2), the shed domain of TREM2. TREM2 is a macrophage receptor mediating lipid uptake and efferocytosis. The goal of this study is to investigate if there is a mechanistic link between full-length TREM2 and apolipoprotein C3 (APOC3), an apolipoprotein that slows TRL catabolism and promotes CVD. We performed complementary analyses of individuals with prediabetes and hepatic steatosis, mouse models, and hepatocyte-macrophage co-cultures. Individuals with prediabetes and hepatic steatosis had higher plasma sTREM2, APOC3, and TRLs than healthy controls matched for age, sex, and BMI (p=1.20x10 -2 , 1.67x10 -3 , and 1.76x10 -2 ; n=10/group). Moreover, plasma sTREM2 correlated positively with plasma APOC3 in a larger cohort of subjects with metabolic dysfunction-associated steatotic liver disease (r 2 =0.28; p=5.29x10 -3 ; n=26). LDL receptor-deficient ( Ldlr -/- ) mice - which, when fed a high-fat high-sucrose diet with added cholesterol develop prediabetes, hepatic steatosis, and atherosclerosis - were used to study the mechanistic link between full-length TREM2 and APOC3 by introducing complete bone marrow engraftment from wildtype (WT) mice, mice deficient in myeloid cell ADAM17 (the main TREM2 sheddase), mice deficient in TREM2, or mice deficient in both myeloid ADAM17 and TREM2. Primary hepatocyte-macrophage co-culture studies revealed that myeloid cell ADAM17-deletion preserved macrophage full-length TREM2, prevented APOC3 secretion from lipid-loaded hepatocytes, and increased efferocytosis of steatotic hepatocytes compared with TREM2-deficient macrophages. In mice with prediabetes and hepatic steatosis, preserving macrophage full-length TREM2 by myeloid-targeted ADAM17-deletion protected against the elevated plasma APOC3, sTREM2, TRLs, and atherosclerosis, while TREM2-deficiency increased APOC3 secretion rate and atherosclerosis, and deficiency in both myeloid ADAM17 and TREM2 resulted in APOC3 levels and atherosclerosis similar to WT mice (all p<0.05, n=8-9/group). Our findings identify macrophage TREM2 shedding as an upstream driver of hepatic APOC3 overproduction, providing a mechanistic link between hepatic steatosis and CVD risk in prediabetes.
Details
- Title: Subtitle
- Abstract Or116: Macrophage full-length TREM2 suppresses hepatic apolipoprotein C3 secretion and atherosclerosis in prediabetic hepatic steatosis
- Creators
- Jingjing Tang - University of WashingtonJenny Kanter - University of WashingtonBaohai Shao - University of WashingtonMasami Shimizu-Albergine - University of WashingtonFarah Kramer - University of WashingtonAHREUM Khang - University of WashingtonJason Luo - University of WashingtonHuaqing Zheng - University of WashingtonAlan Tran - University of WashingtonJocelyn Cervantes - University of WashingtonJeremy Frey - University of WashingtonMauricio Dorfman - University of WashingtonCheng-Chieh Hsu - Columbia UniversityLaura Den HartighTomas Vaisar - Seattle UniversityBrandon Davies - University of IowaAdam Mullick - Ionis Pharmaceuticals (United States)George Ioannou - University of WashingtonGordon Smith - Washington University in St. LouisSamuel Klein - Washington University in St. LouisNicholas Davidson - Washington University in St. LouisKarin Bornfeldt - University of Washington
- Resource Type
- Abstract
- Publication Details
- Arteriosclerosis, thrombosis, and vascular biology, Vol.46(Suppl_1)
- DOI
- 10.1161/atvb.46.suppl_1.Or116
- ISSN
- 1079-5642
- eISSN
- 1524-4636
- Publisher
- American Heart Association
- Language
- English
- Date published
- 05/2026
- Academic Unit
- Fraternal Order of Eagles Diabetes Research Center; Biochemistry and Molecular Biology
- Record Identifier
- 9985215018602771
Metrics
1 Record Views